Clinical Research Facility

Redondo Beach, California 90277

Use our guide to learn which trials are right for you!

We've found
7 trials
at this facility
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Asthma Clinical Trial
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Oral Mucositis Clinical Trial
Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer
Status: Enrolling, Phase II
Updated: 7/6/2016
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
mi
from
Redondo Beach, CA
Click here to add this to my saved trials